Suppression of tumour necrosis factor production from mononuclear cells by a novel synthetic compound, CLX-090717.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 32
- By:
- Publication type:
- Article
Works matching IS 14620324 AND DT 2009 AND VI 48 AND IP 1
Results: 22
1
2
MEFV mutations in systemic onset juvenile idiopathic arthritis.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 23
- By:
- Publication type:
- Article
3
Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 11
- By:
- Publication type:
- Article
4
You say goodbye and I say hello.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 1
- By:
- Publication type:
- Article
5
Mannose-binding lectin-low genotypes are associated with milder systemic and immunological disease expression in primary Sjogrens syndrome.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 65
- By:
- Publication type:
- Article
6
Cyclophosphamide-associated complications: we need to be aware of SIADH and central pontine myelinolysis.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 89
- By:
- Publication type:
- Article
7
Anti-atherogenic and anti-inflammatory properties of high-density lipoprotein are affected by specific antibodies in systemic lupus erythematosus.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 26
- By:
- Publication type:
- Article
8
Imatinib as a novel therapeutic approach for fibrotic disorders.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 2
- By:
- Publication type:
- Article
9
Comment on: Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies: reply.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 90
- By:
- Publication type:
- Article
10
Comment on: Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 90
- Publication type:
- Article
11
Involvement, satisfaction and unmet health care needs in patients with psoriatic arthritis.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 53
- By:
- Publication type:
- Article
12
Risk factors for the development of hip osteoarthritis: a population-based prospective study.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 83
- By:
- Publication type:
- Article
13
Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 70
- By:
- Publication type:
- Article
14
Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 61
- By:
- Publication type:
- Article
15
Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis: the ERAN cohort.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 57, doi. 10.1093/rheumatology/ken406
- By:
- Publication type:
- Article
16
Musculoskeletal pain is associated with a long-term increased risk of cancer and cardiovascular-related mortality.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 74
- By:
- Publication type:
- Article
17
The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 5
- Publication type:
- Article
18
Cordycepin inhibits IL-1{beta}-induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 45
- By:
- Publication type:
- Article
19
A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 49
- By:
- Publication type:
- Article
20
An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 78
- By:
- Publication type:
- Article
21
Lactoferrin is a survival factor for neutrophils in rheumatoid synovial fluid.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 39
- By:
- Publication type:
- Article
22
Resolution of Behcets disease after non-myeloablative allogeneic stem cell transplant for acute myeloid leukaemia.
- Published in:
- Rheumatology, 2009, v. 48, n. 1, p. 88
- By:
- Publication type:
- Article